EU drug regulator to issue view on J&J vaccine side effects on April 20

FILE PHOTO: Vials labelled "COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration reuters_tickers
This content was published on April 16, 2021 - 16:03

FRANKFURT (Reuters) - Europe's drug regulator on Friday said it would hold a press briefing on its review of very rare blood clotting disorders associated with the use of Johnson & Johnson's COVID-19 vaccine on Tuesday, April 20, at 1500 GMT.

The European Medicines Agency (EMA) had previously announced it would provide an update on its review of the cases, which have occurred in the United States, next week. It has so far maintained that the benefits of the shot outweighed the risk of any side effects.

(Reporting by Ludwig Burger; Editing by Tom Sims)

Share this story

Join the conversation!

With a SWI account, you have the opportunity to contribute on our website.

You can Login or register here.